Form D · Biotechnology
SYNPROMICS LTD
Edinburgh, X0 · CIK 0001739278
Offering snapshot reported May 15, 2018 · SEC filing
- Reported sold
- $559 Offering amount: $559
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $559 Reported outside-investor minimum
- First sale
- May 4, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2018 | Initial | $559 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-312398
TOTAL AMOUNT OFFERED AND SOLD WAS GBP412.50. CONVERTED ON AN EXCHANGE RATE OF 1GBP = 1.357USD.
Source: Form D, filed May 15, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Charles Venables | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Roslin Innovation Centre Easter Bush Campus
Edinburgh, X0, EH25 9RG
Edinburgh, X0, EH25 9RG